These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37042969)

  • 1. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
    Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
    Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.
    Singh B; Kedia S; Konijeti G; Mouli VP; Dhingra R; Kurrey L; Srivastava S; Pradhan R; Makharia G; Ahuja V
    Indian J Gastroenterol; 2015 Jan; 34(1):43-50. PubMed ID: 25663290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis].
    Mendoza JL; Lana R; Taxonera C; Alba C; Izquierdo S; Díaz-Rubio M
    Med Clin (Barc); 2005 Sep; 125(8):297-300. PubMed ID: 16159555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
    Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
    Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
    Roth N; Biedermann L; Fournier N; Butter M; Vavricka SR; Navarini AA; Rogler G; Scharl M;
    PLoS One; 2019; 14(1):e0210436. PubMed ID: 30682031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.
    Zippi M; Corrado C; Pica R; Avallone EV; Cassieri C; De Nitto D; Paoluzi P; Vernia P
    World J Gastroenterol; 2014 Dec; 20(46):17463-7. PubMed ID: 25516659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Li JX; Chiang CC; Chen SN; Lin JM; Tsai YY
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
    Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
    Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.
    Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
    Digestion; 2023; 104(4):328-334. PubMed ID: 36893744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
    Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
    J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous manifestations in inflammatory bowel disease.
    Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
    Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A descriptive study of inflammatory bowel disease at an Egyptian tertiary care center.
    El-Atrebi KA; Taher E; El Aguizy FH; Ali RM; Hegazy A; El-Sayed MM; Eysa B; El-Atreby AA; Mohammed AA; El-Bassyouni HT
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(1):12-18. PubMed ID: 34887218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucocutaneous manifestations in inflammatory bowel disease.
    Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N
    Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies.
    Lo B; Zhao M; Vind I; Burisch J
    Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1117-1138.e19. PubMed ID: 32801010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    States V; O'Brien S; Rai JP; Roberts HL; Paas M; Feagins K; Pierce EJ; Baumgartner RN; Galandiuk S
    Dig Dis Sci; 2020 Sep; 65(9):2675-2685. PubMed ID: 31925675
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.